Bayer CropScience Share Price Rises 3.82% as 5.35 Million Shares Change Hands in Block Deal

Bayer CropScience share price climbed 3.82 percent to Rs 4,279.90 on the NSE in early trade on Wednesday, 8 July 2026, after a large block deal caught market attention. Around 5.35 million shares of the agrochemical major, equivalent to 11.9 percent of its total equity, changed hands in a single block, according to Bloomberg data.

The counter opened at Rs 4,202 and touched an intraday high of Rs 4,313.50 within the first few minutes of trade. The identities of the buyer and the seller in the transaction were not immediately available.

Click Here – Get Free Investment Predictions

Bayer CropScience Share Price Today: Key Details of the Block Deal

A block of 5.35 million shares representing 11.9 percent of Bayer CropScience equity was traded on the exchanges on Wednesday. At the prevailing market price, a stake of this size is among the largest single transactions in the stock in recent months.

Metric	Value
Stock	Bayer CropScience
CMP (8 July 2026, NSE)	Rs 4,279.90
Day Change	+3.82 percent
Previous Close (BSE)	Rs 4,117.00 (down 1.33 percent)
Block Size	5.35 million shares (11.9 percent of equity)
52 Week High	Rs 6,539.95 (4 August 2025)
52 Week Low	Rs 4,030.00 (29 June 2026)
Market Capitalisation	Rs 18,502.66 crore

Get Guidance from a SEBI Registered Investment Advisor at Univest

Where Does the Bayer CropScience Share Price Stand Now

The stock is currently trading about 37.05 percent below its 52 week high of Rs 6,539.95 and roughly 2.16 percent above its 52 week low of Rs 4,030, which it touched as recently as 29 June 2026. In the previous session, the share had closed down 1.33 percent, or Rs 55.40, at Rs 4,117 on the BSE.

Bayer CropScience is the Indian arm of German life sciences group Bayer AG and operates in crop protection chemicals, seeds and digital farming solutions. The stock has been under pressure over the past year amid a weak agrochemical demand cycle and pricing pressure across the crop protection industry.

What Should Investors Watch After the Block Deal

Investors will track exchange disclosures for the names of the buyer and seller, since an 11.9 percent stake change can alter the shareholding structure meaningfully. Any clarification from the company on promoter holding, along with the upcoming Q1 FY27 results and monsoon-driven demand commentary, will be the next triggers for the Bayer CropScience share price.

Download the Univest iOS App or Univest Android App to track the Bayer CropScience share price live and get daily stock research.

Conclusion

Bayer CropScience share price rose sharply on 8 July 2026 after 5.35 million shares, or 11.9 percent of equity, traded in a block deal. The stock still trades far below its 52 week high, and counterparty disclosures along with Q1 FY27 earnings will decide the next move. Investors should consult a SEBI registered advisor before acting on block deal news.

Frequently Asked Questions FAQs

What happened in the Bayer CropScience block deal on 8 July 2026?

Ans. Around 5.35 million shares of Bayer CropScience, equivalent to 11.9 percent of the company’s equity, changed hands in a block deal on 8 July 2026, according to Bloomberg data. The buyer and seller were not immediately identified.

What is the Bayer CropScience share price today?

Ans. Bayer CropScience share price was trading at Rs 4,279.90 on the NSE in early trade on 8 July 2026, up 3.82 percent from the previous close.

What is the 52 week high and low of Bayer CropScience?

Ans. Bayer CropScience touched a 52 week high of Rs 6,539.95 on 4 August 2025 and a 52 week low of Rs 4,030.00 on 29 June 2026.

How far is Bayer CropScience from its 52 week high?

Ans. The stock is trading about 37.05 percent below its 52 week high of Rs 6,539.95 and around 2.16 percent above its 52 week low of Rs 4,030.

What is the market capitalisation of Bayer CropScience?

Ans. The market capitalisation of Bayer CropScience stands at approximately Rs 18,502.66 crore.

Should investors buy Bayer CropScience after the block deal?

Ans. A block deal alone is not a buy or sell signal. Investors should wait for counterparty disclosures, review Q1 FY27 earnings and consult a SEBI registered investment advisor before taking any decision.